Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Dhariwalcorp
Quarter-by-quarter operating performance
Financials of Dhariwalcorp
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 159 | 194 | 229 | 233 | 236 |
| Expenses + | 157 | 194 | 224 | 230 | 230 |
| Operating Profit | 2 | 0 | 4 | 3 | 6 |
| OPM % | 1% | 0% | 2% | 1% | 3% |
| Other Income + | 1 | 1 | 2 | 3 | 7 |
| Interest | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 1 | 6 | 5 | 11 |
| Tax % | 24% | 31% | 25% | 29% | 24% |
| Net Profit + | 1 | 1 | 5 | 4 | 9 |
| EPS in Rs | 14.20 | 6.00 | 0.68 | 0.40 | 0.91 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of Dhariwalcorp
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 7 | 9 | 19 |
| Reserves | 2 | 2 | 2 | 26 | 43 |
| Borrowings + | 6 | 6 | 9 | 11 | 8 |
| Other Liabilities + | 6 | 11 | 4 | 22 | 10 |
| Total Liabilities | 14 | 20 | 21 | 68 | 79 |
| Fixed Assets + | 2 | 2 | 2 | 6 | 15 |
| CWIP | 0 | 0 | 3 | 3 | 7 |
| Investments | 0 | 0 | 0 | 4 | 7 |
| Other Assets + | 12 | 18 | 17 | 54 | 50 |
| Total Assets | 14 | 20 | 21 | 68 | 79 |
Financials of Dhariwalcorp
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | 1 | 1 | -0 | -13 | |
| Cash from Investing Activity + | -0 | 0 | -3 | -11 | |
| Cash from Financing Activity + | -1 | -1 | 4 | 24 | |
| Net Cash Flow | 0 | 0 | 0 | -0 | |
| Free Cash Flow | 1 | 1 | -4 | -18 | |
| CFO/OP | 80% | 329% | 23% | -379% |
Financials of Dhariwalcorp
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 20 | 21 | 12 | 26 | 17 |
| Inventory Days | 4 | 9 | 8 | 43 | 40 |
| Days Payable | 9 | 18 | 4 | 29 | 7 |
| Cash Conversion Cycle | 15 | 12 | 17 | 41 | 50 |
| Working Capital Days | 2 | 3 | 10 | 38 | 62 |
| ROCE % | 18% | 50% | 19% | 22% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…